Quick Answer
Vicapsys Life Sciences, Inc. reported Total Assets of $39.7 thousand for the year ending 2023.
- Vicapsys Life Sciences, Inc. showed a decrease of -44.9% in Total Assets from 2022 to 2023.
- This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
- XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $461.0 thousand | Q2 2020: $427.4 thousand | Q3 2020: $414.3 thousand | Q1 2021: $428.4 thousand | Q2 2021: $562.4 thousand | Q3 2021: $552.2 thousand | Q1 2022: $478.2 thousand | Q2 2022: $382.2 thousand | Q3 2022: $383.8 thousand | Q1 2023: $63.3 thousand | Q2 2023: $378.1 thousand | Q3 2023: $208.5 thousand | Q4 2023: $39.7 thousand | Q3 2024: $89.6 thousand.
- Over the full 5 years of available data (2019 to 2023), Vicapsys Life Sciences, Inc.'s Total Assets has declined by 94.3%.
- Historical annual values: Fiscal year 2023: $39.7 thousand | Fiscal year 2022: $72.0 thousand | Fiscal year 2021: $594.3 thousand | Fiscal year 2020: $404.1 thousand | Fiscal year 2019: $698.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: